论文部分内容阅读
目的探讨剖宫产术围手术期用药的临床对策。方法 80例行剖宫产术产妇,随机分成观察组和对照组,各40例。观察组产妇采用围手术期抗感染用药治疗,对照组产妇采用围手术期常规用药治疗,对比不同用药后的治疗效果。结果观察组产妇术后退热时间为(1.45±1.07)d,术后最高体温为(37.80±0.20)℃,术后腹部切口感染率为2.5%(1/40),产褥病发生率为2.5%(1/40);对照组产妇术后退热时间为(2.68±1.8)d,术后最高体温为(38.31±0.28)℃,术后腹部切口感染率为15.0%(6/40),产褥病发生率为17.5%(7/40);两组产妇术后退热时间、最高体温及腹部切口感染率、产褥病发生率比较,差异均有统计学意义(P<0.05)。结论剖宫产术产妇在围手术期给予抗感染用药治疗可明显缩短预防性使用抗菌药的使用时间,降低切口感染率及产褥病发生率。
Objective To explore the clinical strategy of cesarean section perioperative medication. Methods 80 cases of cesarean section maternal, were randomly divided into observation group and control group, 40 cases each. The observation group maternal perioperative anti-infective drug treatment, the control group of maternal perioperative routine drug treatment, compared to different treatment effect after treatment. Results The postoperative pyrexia onset time was (1.45 ± 1.07) d in postoperative observation group, the postoperative maximum body temperature was (37.80 ± 0.20) ℃ and the rate of postoperative abdominal incision infection was 2.5% (1/40). The incidence of puerperal disease was (2.68 ± 1.8) days postoperatively, and the highest postoperative temperature was (38.31 ± 0.28) ℃. The infection rate of postoperative abdominal incision was 15.0% (6/40) , And the incidence of putrid disease was 17.5% (7/40). There was significant difference between the two groups in the postoperative fever, the highest body temperature, the incision infection rate and the incidence of puerperal disease (P <0.05) . Conclusion Maternal cesarean section in the perioperative anti-infective medication can significantly reduce the use of preventive antibacterials, reduce the incision infection rate and the incidence of puerperal.